Genovese Burford & Brothers Wealth & Retirement Plan Management LLC maintained its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,812 shares of the pharmacy operator’s stock at the end of the second quarter. Genovese Burford & Brothers Wealth & Retirement Plan Management LLC’s holdings in Walgreens Boots Alliance were worth $141,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. Nordea Investment Management AB boosted its position in shares of Walgreens Boots Alliance by 26.5% during the 1st quarter. Nordea Investment Management AB now owns 9,154,328 shares of the pharmacy operator’s stock valued at $760,267,000 after acquiring an additional 1,917,082 shares during the last quarter. Wellington Management Group LLP boosted its position in shares of Walgreens Boots Alliance by 5.9% during the 1st quarter. Wellington Management Group LLP now owns 32,846,862 shares of the pharmacy operator’s stock valued at $2,727,932,000 after acquiring an additional 1,824,300 shares during the last quarter. TIAA CREF Investment Management LLC boosted its position in shares of Walgreens Boots Alliance by 22.4% during the 1st quarter. TIAA CREF Investment Management LLC now owns 5,269,500 shares of the pharmacy operator’s stock valued at $437,632,000 after acquiring an additional 962,959 shares during the last quarter. UBS Asset Management Americas Inc. boosted its position in shares of Walgreens Boots Alliance by 22.9% during the 1st quarter. UBS Asset Management Americas Inc. now owns 4,912,489 shares of the pharmacy operator’s stock valued at $407,982,000 after acquiring an additional 914,888 shares during the last quarter. Finally, Prudential Financial Inc. boosted its position in shares of Walgreens Boots Alliance by 53.0% during the 1st quarter. Prudential Financial Inc. now owns 2,211,112 shares of the pharmacy operator’s stock valued at $183,632,000 after acquiring an additional 766,200 shares during the last quarter. 60.16% of the stock is owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: “Walgreens Boots Alliance, Inc. (WBA) Position Held by Genovese Burford & Brothers Wealth & Retirement Plan Management LLC” was originally published by Watch List News and is owned by of Watch List News. If you are reading this article on another site, it was copied illegally and republished in violation of US and international copyright & trademark laws. The correct version of this article can be read at https://www.watchlistnews.com/walgreens-boots-alliance-inc-wba-position-held-by-genovese-burford-brothers-wealth-retirement-plan-management-llc/1579240.html.

WBA has been the subject of a number of research analyst reports. Jefferies Group LLC dropped their price target on Walgreens Boots Alliance from $95.00 to $80.00 and set a “buy” rating for the company in a research report on Wednesday, May 31st. Zacks Investment Research downgraded Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research report on Wednesday, June 14th. BidaskClub downgraded Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research report on Saturday, June 24th. Needham & Company LLC initiated coverage on Walgreens Boots Alliance in a research report on Tuesday, June 27th. They set a “hold” rating for the company. Finally, Goldman Sachs Group, Inc. (The) reiterated a “neutral” rating and set a $77.00 price target (down previously from $89.00) on shares of Walgreens Boots Alliance in a research report on Wednesday, June 28th. Two analysts have rated the stock with a sell rating, three have assigned a hold rating and fifteen have given a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus target price of $92.06.

Shares of Walgreens Boots Alliance, Inc. (NASDAQ WBA) opened at 78.20 on Friday. The company has a market cap of $83.68 billion, a P/E ratio of 19.75 and a beta of 1.26. The firm has a 50-day moving average price of $81.36 and a 200 day moving average price of $81.86. Walgreens Boots Alliance, Inc. has a 12 month low of $75.18 and a 12 month high of $89.69.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 earnings per share for the quarter, beating the consensus estimate of $1.30 by $0.03. The business had revenue of $30.12 billion during the quarter, compared to analysts’ expectations of $29.72 billion. Walgreens Boots Alliance had a return on equity of 17.34% and a net margin of 3.69%. The firm’s revenue for the quarter was up 2.1% compared to the same quarter last year. During the same quarter last year, the business posted $1.18 EPS. Equities analysts predict that Walgreens Boots Alliance, Inc. will post $5.00 earnings per share for the current year.

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 12th. Shareholders of record on Friday, August 18th were issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 2.03%. The ex-dividend date of this dividend was Wednesday, August 16th. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 40.30%.

Walgreens Boots Alliance announced that its board has initiated a stock repurchase plan on Thursday, June 29th that authorizes the company to repurchase $5.00 billion in shares. This repurchase authorization authorizes the pharmacy operator to purchase up to 5.9% of its shares through open market purchases. Shares repurchase plans are often a sign that the company’s board of directors believes its shares are undervalued.

In other news, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction that occurred on Tuesday, July 25th. The stock was sold at an average price of $79.79, for a total value of $218,305.44. Following the completion of the sale, the director now directly owns 19,151 shares of the company’s stock, valued at approximately $1,528,058.29. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 13.50% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.